These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31317370)

  • 1. Vanishing bile duct syndrome arising in a patient with HIV infection sequentially treated with trimethoprim/sulfamethoxazole and dapsone.
    Kathi PR; Tama M; Ehrinpreis M; Mutchnick M; Westerhoff M; Mowers J; Fontana RJ
    Clin J Gastroenterol; 2020 Apr; 13(2):276-280. PubMed ID: 31317370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome.
    Yao F; Behling CA; Saab S; Li S; Hart M; Lyche KD
    Am J Gastroenterol; 1997 Jan; 92(1):167-9. PubMed ID: 8995964
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
    Safrin S; Finkelstein DM; Feinberg J; Frame P; Simpson G; Wu A; Cheung T; Soeiro R; Hojczyk P; Black JR
    Ann Intern Med; 1996 May; 124(9):792-802. PubMed ID: 8610948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
    Medina I; Mills J; Leoung G; Hopewell PC; Lee B; Modin G; Benowitz N; Wofsy CB
    N Engl J Med; 1990 Sep; 323(12):776-82. PubMed ID: 2392131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
    Antinori A; Murri R; Ammassari A
    AIDS; 1996 Aug; 10(9):1046-7. PubMed ID: 8853743
    [No Abstract]   [Full Text] [Related]  

  • 6. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
    Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.
    Beumont MG; Graziani A; Ubel PA; MacGregor RR
    Am J Med; 1996 Jun; 100(6):611-6. PubMed ID: 8678080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone.
    Holtzer CD; Flaherty JF; Coleman RL
    Pharmacotherapy; 1998; 18(4):831-5. PubMed ID: 9692656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe and long lasting cholestasis after high-dose co-trimoxazole treatment for Pneumocystis pneumonia in HIV-infected patients--a report of two cases.
    Hanses F; Zierhut S; Schölmerich J; Salzberger B; Wrede CE
    Int J Infect Dis; 2009 Nov; 13(6):e467-9. PubMed ID: 19299179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia.
    Blum RN; Miller LA; Gaggini LC; Cohn DL
    J Acquir Immune Defic Syndr (1988); 1992; 5(4):341-7. PubMed ID: 1548570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC; Griffith L; Guyatt GH; Opravil M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal hepatic lesions on magnetic resonance imaging induced by trimethoprim/sulfamethoxazole in HIV infection.
    Takahashi T; Taguchi H; Nakamura T; Yoshikawa K; Iwamoto A
    Ann Pharmacother; 1999 Sep; 33(9):1007-8. PubMed ID: 10492507
    [No Abstract]   [Full Text] [Related]  

  • 13. Identifying the Cause of the "Saturation Gap": Two Cases of Dapsone-induced Methemoglobinemia.
    Furuta K; Ikeo S; Takaiwa T; Ikeda S; Nishiyama A; Yokoyama T; Ito A; Tokioka F; Tanaka M; Yoshioka H; Tachibana H; Arita M; Hashimoto T; Ishida T
    Intern Med; 2015; 54(13):1639-41. PubMed ID: 26134197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia.
    Yang JJ; Huang CH; Liu CE; Tang HJ; Yang CJ; Lee YC; Lee KY; Tsai MS; Lin SW; Chen YH; Lu PL; Hung CC
    PLoS One; 2014; 9(9):e106141. PubMed ID: 25184238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
    Barber BA; Pegram PS; High KP
    Clin Infect Dis; 1996 Oct; 23(4):718-22. PubMed ID: 8909833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.
    Urbancic KF; Pisasale D; Wight J; Trubiano JA
    Transpl Infect Dis; 2018 Dec; 20(6):e12968. PubMed ID: 30030892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
    El-Sadr WM; Murphy RL; Yurik TM; Luskin-Hawk R; Cheung TW; Balfour HH; Eng R; Hooton TM; Kerkering TM; Schutz M; van der Horst C; Hafner R
    N Engl J Med; 1998 Dec; 339(26):1889-95. PubMed ID: 9862944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole.
    Altraif I; Lilly L; Wanless IR; Heathcote J
    Am J Gastroenterol; 1994 Aug; 89(8):1230-4. PubMed ID: 8053440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful desensitization to dapsone for Pneumocystis carinii prophylaxis in an HIV-positive patient.
    Cook DE; Kossey JL
    Ann Pharmacother; 1998 Dec; 32(12):1302-5. PubMed ID: 9876811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycetoma vs nocardiosis.
    Arenas R
    J Dermatol; 1997 Jan; 24(1):68. PubMed ID: 9046748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.